Tag Archives: drug companies

Taxes on Drug and Device Companies Removed in Repeal Plan: Insurers and Health Care Industry Concerns

Repeal proposes cutting taxes on Pharmaceutical and Medical Devise Companies while raising costs for elderly and those with pre-existing conditions.  The CEO of Blue Cross of California opposes current reform proposals, citing cost increases for individuals and families and harm … Continue reading

Posted in Affordable Care Act, budget cuts, consumer protection, Health Care Reform, seniors, technology and pharmaceutical costs | Tagged , , , , | Leave a comment

Congress Tackles Drug Prices: Much Bipartisan Support; and Recent Trends in Drug Costs Here and What Other Countries Pay

Finally it looks like Congress might just re-visit Medicare Part D and let Medicare negotiate rates with drug companies.   See charts below: http://www.statnews.com/2015/12/01/stat-harvard-drug-prices-poll/  The VA and Medicaid can negotiate rates. Senate Special Committee on Aging holds drug costs hearing December … Continue reading

Posted in aging, Economy, media, Medicare, pharmaceutical companies, policy and politics, politics, prescription drugs, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

How Businesses Fared in Massachusetts; Drug Companies Payment to Physicians; Rush Out and Read; Berwick for Governor; and Egan on Health Care

In 2006, Massachusetts passed health care legislation that is remarkably similar to the Affordable Care Act (ACA).  Like the ACA, the Massachusetts law focused on expanding health insurance for all the state’s 6.5 million residents. Key provisions of the law … Continue reading

Posted in budget cuts, business, Economy, Health Care Reform, health insurance, Medicare, policy and politics | Tagged , , , , , , , , | Leave a comment